CARDIONET, INC. Research and Development Expense
CARDIONET, INC. reported Research and Development Expense of $1.62 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-04-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2013-04-30
- CARDIONET, INC. research and development expense for the quarter ending 2013-03-31 was $1.62M, a 36.71% increase year-over-year.
- CARDIONET, INC. research and development expense for the quarter ending 2012-12-31 was $1.30M, a 2.26% decline year-over-year.
- CARDIONET, INC. research and development expense for the quarter ending 2012-09-30 was $1.14M, a 14.00% decline year-over-year.
- CARDIONET, INC. research and development expense for the quarter ending 2012-06-30 was $1.04M, a 23.59% decline year-over-year.
- CARDIONET, INC. research and development expense for fiscal 2012 was $4.66M, a 18.15% decline from fiscal 2011.
- CARDIONET, INC. research and development expense for fiscal 2011 was $5.70M, a 16.36% increase from fiscal 2010.
- CARDIONET, INC. research and development expense for fiscal 2010 was $4.90M, a 15.71% decline from fiscal 2009.
- CARDIONET, INC. research and development expense for fiscal 2009 was $5.81M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2013-03-31 | $1.62M 10-Q · filed 2013-04-30 | $2.92M derived: sum of 2 quarters · filed 2013-04-30 | $4.06M derived: sum of 3 quarters · filed 2013-04-30 | $5.10M derived: sum of 4 quarters · filed 2013-04-30 |
| 2012-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $2.44M derived: sum of 2 quarters · filed 2013-02-22 | $3.48M derived: sum of 3 quarters · filed 2013-02-22 | $4.66M 10-K · filed 2013-02-22 |
| 2012-09-30 | $1.14M 10-Q · filed 2012-11-05 | $2.18M derived: sum of 2 quarters · filed 2012-11-05 | $3.37M 10-Q · filed 2012-11-05 | $4.69M derived: sum of 4 quarters · filed 2013-04-30 |
| 2012-06-30 | $1.04M 10-Q · filed 2012-08-09 | $2.23M 10-Q · filed 2012-08-09 | $3.55M derived: sum of 3 quarters · filed 2013-04-30 | $4.88M derived: sum of 4 quarters · filed 2013-04-30 |
| 2012-03-31 | $1.19M 10-Q · filed 2013-04-30 | $2.51M derived: sum of 2 quarters · filed 2013-04-30 | $3.84M derived: sum of 3 quarters · filed 2013-04-30 | $5.20M derived: sum of 4 quarters · filed 2013-04-30 |
| 2011-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $2.65M derived: sum of 2 quarters · filed 2013-02-22 | $4.02M derived: sum of 3 quarters · filed 2013-02-22 | $5.70M 10-K · filed 2013-02-22 |
| 2011-09-30 | $1.33M 10-Q · filed 2012-11-05 | $2.69M derived: sum of 2 quarters · filed 2012-11-05 | $4.37M 10-Q · filed 2012-11-05 | $5.56M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-06-30 | $1.36M 10-Q · filed 2012-08-09 | $3.04M 10-Q · filed 2012-08-09 | $4.23M derived: sum of 3 quarters · filed 2013-02-22 | $5.47M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | $1.68M 10-Q · filed 2012-05-10 | $2.87M derived: sum of 2 quarters · filed 2013-02-22 | $4.11M derived: sum of 3 quarters · filed 2013-02-22 | $5.34M derived: sum of 4 quarters · filed 2013-02-22 |
| 2010-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $2.42M derived: sum of 2 quarters · filed 2013-02-22 | $3.65M derived: sum of 3 quarters · filed 2013-02-22 | $4.90M 10-K · filed 2013-02-22 |
| 2010-09-30 | $1.24M 10-Q · filed 2011-11-09 | $2.47M derived: sum of 2 quarters · filed 2011-11-09 | $3.71M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $1.23M 10-Q · filed 2011-08-09 | $2.47M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $5.81M 10-K · filed 2012-02-23 |